Issued 2026-09-25 at $7.94 · now $7.94 (2026-09-25, +0.0% since)
Based on its own history, a month from the 2026-09-25 close, DMAC has typically landed between $6.01 and $10.87 — a range of −24.3% to +37.0% from the issuance price $7.94.
- Actual close
- Typical path (median)
- Middle 50% of outcomes
- 90% range
3,532 overlapping 1 month windows · 2012-08-03 – 2026-08-26 · basis climatology · forecast (batch). Base rate up 53.7% (90% CI 51.5–55.9%, ≈1,391 obs). Not a call on this stock — we have no evidence its odds differ.
The cone is anchored at the 2026-09-25 issuance close ($7.94) — the price the forecast resolves against on 2026-10-26, not the latest close. The drawn path shape is illustrative (bands widen with √t); every labeled number is real — the anchor, the scored batch p90/IQR endpoints, and the typical move.
Where DMAC has typically landed a month from the 2026-09-25 close of $7.94 — the range is history, not a prediction.
- now $7.94 (+0.0%)
- typicalThe typical outcome — half of similar past periods did better and half did worse (not an average, so a few wild periods don't skew it). $7.97 (+0.4%)
- middle 50%The central range of outcomes — half of similar past periods landed inside it, a quarter finished above, a quarter below. $7.06–$8.88
- 90% rangeA nine-in-ten range — in about nine of every ten similar past periods the outcome stayed within these bounds. $6.01–$10.87
| Start | Return | Max drop | Max rise |
|---|---|---|---|
| 3 worst | |||
| 2014-11-12 | −91.6% | −91.6% | +0.0% |
| 2014-11-13 | −91.6% | −91.6% | +0.0% |
| 2014-11-14 | −91.6% | −91.6% | +0.0% |
| 3 best | |||
| 2020-11-23 | +118.8% | +0.0% | +118.8% |
| 2023-05-12 | +100.6% | +0.0% | +100.6% |
| 2023-05-17 | +100.0% | +0.0% | +100.0% |
3,532 overlapping windows · 2012-08-03 – 2026-09-25 · not cherry-picked
Pending catalysts
- December 2026 — Trial primary completion: Phase 2/Phase PHASE3 primary completion: Treatment of Acute Ischemic Stroke (ReMEDy2 Trial) (source, as of 2026-08-14)
Public, scheduled events — dated attention, not a prediction of the outcome. See the FDA catalysts page for the historical base rate.
Seasonality · by month iHow this security has tended to do in each calendar month historically — a frequency, never a prediction.
iFor each calendar month, the share of years this security closed higher than the month before, and the average month-over-month return, over ~15 years of its own price history. Cells are shaded by average return. This is historical frequency, not a prediction — no month is a signal.Up-frequency and average month-over-month return · historical frequency, not a prediction
Reported insider & political trades
Every Form 4 the people closest to this company have filed with the SEC — plotted against the share price, aggregated by month, and shown with the gap between when each trade happened and when it was disclosed. A public record, not advice.
| Date | Person | Role | Action | Shares @ price | Value | Ownership Δ | vs S&P 1m | vs S&P 6m | Owned after | Filing |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025-11-25 | STAHLBERG JAN | tenPercentOwner | Purchase | 73,099 @ $8.57 | $627K | +0.8% of holding | −11.4% | −46.4% | 8,825,742 | Form 4 · filed 13 days after the trade |
| 2025-11-24 | STAHLBERG JAN | tenPercentOwner | Purchase | 40,253 @ $7.89 | $318K | +0.5% of holding | +2.3% | −36.5% | 8,752,643 | Form 4 · filed 14 days after the trade |
| 2025-11-21 | STAHLBERG JAN | tenPercentOwner | Purchase | 208,872 @ $7.41 | $1.5M | +2.5% of holding | +4.7% | −34.6% | 8,712,390 | Form 4 · filed 17 days after the trade |
| 2025-11-20 | STAHLBERG JAN | tenPercentOwner | Purchase | 128,426 @ $7.41 | $951K | +1.5% of holding | +11.6% | −28.1% | 8,503,518 | Form 4 · filed 18 days after the trade |
| 2025-11-19 | STAHLBERG JAN | tenPercentOwner | Purchase | 240,352 @ $7.21 | $1.7M | +3.0% of holding | +13.2% | −32.2% | 8,375,092 | Form 4 · filed 19 days after the trade |
| 2025-11-18 | STAHLBERG JAN | tenPercentOwner | Purchase | 182,882 @ $6.75 | $1.2M | +2.3% of holding | +18.0% | −29.5% | 8,134,740 | Form 4 · filed 20 days after the trade |
| 2025-11-17 | STAHLBERG JAN | tenPercentOwner | Purchase | 187,393 @ $6.52 | $1.2M | +2.4% of holding | +27.2% | −22.8% | 7,951,858 | Form 4 · filed 21 days after the trade |
| 2025-08-27 | STAHLBERG JAN | tenPercentOwner | Purchase | 50,772 @ $6.00 | $305K | +0.7% of holding | +13.4% | +26.2% | 7,764,465 | Form 4 · filed 8 days after the trade |
| 2025-08-26 | STAHLBERG JAN | tenPercentOwner | Purchase | 59,648 @ $6.00 | $358K | +0.8% of holding | +10.8% | +28.6% | 7,713,693 | Form 4 · filed 9 days after the trade |
| 2025-08-25 | STAHLBERG JAN | tenPercentOwner | Purchase | 338,265 @ $6.00 | $2.0M | +4.6% of holding | +11.0% | +33.2% | 7,654,045 | Form 4 · filed 10 days after the trade |
| 2025-08-22 | STAHLBERG JAN | tenPercentOwner | Purchase | 59,788 @ $5.96 | $357K | +0.8% of holding | +9.2% | +32.8% | 7,315,780 | Form 4 · filed 13 days after the trade |
| 2025-08-21 | STAHLBERG JAN | tenPercentOwner | Purchase | 48,172 @ $5.96 | $287K | +0.7% of holding | +12.5% | +32.1% | 7,255,992 | Form 4 · filed 14 days after the trade |
| 2025-08-20 | STAHLBERG JAN | tenPercentOwner | Purchase | 71,107 @ $5.86 | $416K | +1.0% of holding | +9.4% | +31.7% | 7,207,820 | Form 4 · filed 15 days after the trade |
| 2025-08-15 | STAHLBERG JAN | tenPercentOwner | Purchase | 8,233 @ $6.00 | $49K | +0.1% of holding | +13.0% | +37.5% | 7,136,713 | Form 4 · filed 20 days after the trade |
| 2025-08-14 | STAHLBERG JAN | tenPercentOwner | Purchase | 70,414 @ $5.99 | $422K | +1.0% of holding | +14.2% | +35.6% | 7,128,480 | Form 4 · filed 21 days after the trade |
| 2025-08-13 | STAHLBERG JAN | tenPercentOwner | Purchase | 293,601 @ $5.91 | $1.7M | +4.3% of holding | +16.2% | +37.6% | 7,058,066 | Form 4 · filed 22 days after the trade |
| 2025-07-23 | Von Koch Thomas | tenPercentOwner | Purchase | 2,857,142 @ $3.50 | $10.0M | +51.7% of holding | +14.9% | +52.5% | 8,383,577 | Form 4 · filed 2 days after the trade |
| 2025-07-23 | STAHLBERG JAN | tenPercentOwner | Purchase | 1,542,857 @ $3.50 | $5.4M | +29.5% of holding | +14.9% | +52.5% | 6,764,465 | Form 4 · filed 2 days after the trade |
| 2025-07-23 | JACINTO RICHARD II | tenPercentOwner | Purchase | 400,000 @ $3.50 | $1.4M | +8.8% of holding | +14.9% | +52.5% | 4,958,823 | Form 4 · filed 2 days after the trade |
| 2024-06-28 | Von Koch Thomas | tenPercentOwner | Purchase | 1,200,000 @ $2.50 | $3.0M | +27.7% of holding | +22.8% | +73.4% | 5,526,435 | Form 4 · filed 3 days after the trade |
| 2024-06-28 | STAHLBERG JAN | tenPercentOwner | Purchase | 1,200,000 @ $2.50 | $3.0M | +29.8% of holding | +22.8% | +73.4% | 5,221,608 | Form 4 · filed 3 days after the trade |
The vs-S&P columns are a labeled look-back on what the stock did after each filing, measured against the index over the same window. Descriptive history, not a claim about the person or a reason to trade.
47 award / exercise / gift records — not counted as purchases
Awards, option exercises, gifts and tax-withholding disposals are shown separately and never counted as open-market purchases or sales — they carry no conviction information.
| Date | Person | Role | Action | Shares | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-08-10 | Pauls Dietrich John | director | Award / grant | 60,200 | 128,791 | Form 4 |
| 2026-06-01 | O'Connor Daniel J. | director | Award / grant | 40,412 | 40,412 | Form 4 |
| 2026-06-01 | Lewis Tanya | director | Award / grant | 40,412 | 40,412 | Form 4 |
| 2026-06-01 | Kellen Scott | officer | Award / grant | 162,000 | 162,000 | Form 4 |
| 2026-06-01 | Krop Julie | director | Award / grant | 67,500 | 67,500 | Form 4 |
| 2026-06-01 | Giuffre Randall Michael | director | Award / grant | 40,412 | 40,412 | Form 4 |
| 2026-06-01 | Parsons James T. | director | Award / grant | 51,189 | 51,189 | Form 4 |
| 2026-06-01 | Pauls Dietrich John | director | Award / grant | 380,000 | 380,000 | Form 4 |
| 2026-06-01 | Semba Charles Pauling | director | Award / grant | 40,412 | 40,412 | Form 4 |
| 2026-06-01 | Kuntz Richard | director | Award / grant | 40,412 | 40,412 | Form 4 |
| 2026-01-02 | Parsons James T. | director | Award / grant | 10,095 | 97,949 | Form 4 |
| 2026-01-02 | Giuffre Randall Michael | director | Award / grant | 6,175 | 398,587 | Form 4 |
| 2026-01-02 | Semba Charles Pauling | director | Award / grant | 3,355 | 47,963 | Form 4 |
| 2025-11-21 | Parsons James T. | director | Option exercise | 12,000 | 87,854 | Form 4 |
| 2025-11-21 | Parsons James T. | director | Option exercise | 12,000 | 0 | Form 4 |
| 2025-08-11 | Krop Julie | director | Award / grant | 450,000 | 450,000 | Form 4 |
| 2025-06-01 | Giuffre Randall Michael | director | Award / grant | 32,162 | 32,162 | Form 4 |
| 2025-06-01 | Parsons James T. | director | Award / grant | 40,739 | 40,739 | Form 4 |
| 2025-06-01 | Pauls Dietrich John | director | Award / grant | 600,000 | 600,000 | Form 4 |
| 2025-06-01 | Semba Charles Pauling | director | Award / grant | 32,162 | 32,162 | Form 4 |
| 2025-06-01 | Kellen Scott | officer | Award / grant | 225,000 | 225,000 | Form 4 |
| 2025-06-01 | Kuntz Richard | director | Award / grant | 32,162 | 32,162 | Form 4 |
| 2025-06-01 | Lewis Tanya | director | Award / grant | 32,162 | 32,162 | Form 4 |
| 2025-06-01 | Wambeke David J. | officer | Award / grant | 250,000 | 250,000 | Form 4 |
| 2025-04-07 | Pilnik Richard D. | director | Option exercise | 24,000 | 312,995 | Form 4 |
| 2025-04-07 | Pilnik Richard D. | director | Option exercise | 24,000 | 0 | Form 4 |
| 2025-02-20 | O'Connor Daniel J. | director | Award / grant | 64,242 | 64,242 | Form 4 |
| 2025-02-13 | Giuffre Randall Michael | director | Option exercise | 12,000 | 387,412 | Form 4 |
| 2025-02-13 | Giuffre Randall Michael | director | Option exercise | 5,000 | 392,412 | Form 4 |
| 2025-02-13 | Giuffre Randall Michael | director | Option exercise | 5,000 | 0 | Form 4 |
| 2025-02-13 | Giuffre Randall Michael | director | Option exercise | 12,000 | 0 | Form 4 |
| 2025-01-02 | Parsons James T. | director | Award / grant | 15,917 | 75,854 | Form 4 |
| 2025-01-02 | Giuffre Randall Michael | director | Award / grant | 10,861 | 375,412 | Form 4 |
| 2025-01-02 | Pilnik Richard D. | director | Award / grant | 10,393 | 288,995 | Form 4 |
| 2025-01-02 | Kuntz Richard | director | Award / grant | 9,925 | 24,210 | Form 4 |
| 2025-01-02 | Semba Charles Pauling | director | Award / grant | 5,290 | 44,608 | Form 4 |
| 2025-01-02 | Parsons James T. | director | Award / grant | 4,287 | 4,287 | Form 4 |
| 2024-06-01 | Kuntz Richard | director | Award / grant | 28,472 | 28,472 | Form 4 |
| 2024-06-01 | Lewis Tanya | director | Award / grant | 28,472 | 28,472 | Form 4 |
| 2024-06-01 | Parsons James T. | director | Award / grant | 28,472 | 28,472 | Form 4 |
Source: SEC Form 4 filings. Each row links to its original filing.
Across 2012–2021, stocks where a CEO, C-suite officer, or director had recently made an open-market common-stock purchase ran about +28 bp per month above the universe average (n=34,268 stock-weeks). A historical tendency, not a prediction.
Congressional disclosures
No congressional trades disclosed for this company.
Research tool, not investment advice — historical frequencies, not recommendations. A product of Marovel Technologies LLC. Full terms.